Literature DB >> 32517743

The validity and reliability of the PHQ-9 in screening for post-stroke depression.

Piyapat Dajpratham1, Panate Pukrittayakamee2, Wanlop Atsariyasing2, Kamonporn Wannarit2, Jariya Boonhong3, Krit Pongpirul4.   

Abstract

BACKGROUND: Depression affects about 30% of stroke survivors within 5 years. Timely diagnosis and management of post-stroke depression facilitate motor recovery and improve independence. The original version of the Patient Health Questionnaire-9 (PHQ-9) is recognized as a good screening tool for post-stroke depression. However, no validation studies have been undertaken for the use of the Thai PHQ-9 in screening for depression among Thai stroke patients.
METHODS: The objectives were to determine the criterion validity and reliability of the Thai PHQ-9 in screening for post-stroke depression by comparing its results with those of a psychiatric interview as the gold standard. First-ever stroke patients aged ≥45 years with a stroke duration 2 weeks-2 years were administered the Thai PHQ-9. The gold standard was a psychiatric interview leading to a DSM-5 diagnosis of depressive disorder and adjustment disorder with a depressed mood. The summed-scored-based diagnosis of depression with the PHQ-9 was obtained. Validity and reliability analyses, and a receiver operating characteristic curve analysis, were performed.
RESULTS: In all, 115 stroke patients with a mean age of 64 years (SD: 10 years) were enrolled. The mean PHQ-9 score was 5.2 (SD: 4.8). Using the DSM-5 criteria, 11 patients (9.6%) were diagnosed with depressive disorder, 12 patients (10.5%) were diagnosed with adjustment disorder with a depressed mood. Both disorders were combined as a group of post-stroke depression. The Thai PHQ-9 had satisfactory internal consistency (Cronbach's alpha: 0.78). The algorithm-based diagnosis of the Thai PHQ-9 had low sensitivity (0.52) but very high specificity (0.94) and positive likelihood ratio (9.6). Used as a summed-scored-based diagnosis, an optimal cut-off score of six revealed a sensitivity of 0.87, specificity of 0.75, positive predictive value of 0.46, negative predictive value of 0.95, and positive likelihood ratio of 3.5. The area under the curve was 0.87 (95% CI: 0.78-0.96).
CONCLUSIONS: The Thai PHQ-9 has acceptable psychometric properties for detecting a mixture of major depression and adjustment disorder in post-stroke patients, with a recommended cut-off score of ≥6 for a Thai population.

Entities:  

Keywords:  Depression; Patient Health Questionnaire-9; Reliability; Screening; Stroke; Thai; Validity

Year:  2020        PMID: 32517743     DOI: 10.1186/s12888-020-02699-6

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  8 in total

1.  Mediating Role of Resourcefulness in the Relationship Between Illness Uncertainty and Poststroke Depression.

Authors:  Jing Liu; Hongxia Wang; Beibei Lin; Liuqiao Ning; Danman Liu; Jufang Li
Journal:  Front Psychol       Date:  2022-05-12

2.  Prevalence, Severity, and Predictors of Poststroke Depression in a Prospective Cohort of Jordanian Patients.

Authors:  Majdi Al Qawasmeh; Belal Aldabbour; Amal Abuabada; Khalid Abdelrahman; Samah Elamassie; Mays Khweileh; Mohammad Zahran; Khalid El-Salem
Journal:  Stroke Res Treat       Date:  2022-01-07

3.  Selective Impairment of Processing Task-Irrelevant Emotional Faces in Cerebral Small Vessel Disease Patients.

Authors:  Zhongyu Fan; Yunliang Guo; Xunyao Hou; Renjun Lv; Shanjing Nie; Song Xu; Jian Chen; Yan Hong; Shuo Zhao; Xueping Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-16       Impact factor: 2.570

4.  The validity and reliability of the PHQ-9 on screening of depression in neurology: a cross sectional study.

Authors:  Yajing Sun; Zhifei Kong; Yuqing Song; Jing Liu; Xilin Wang
Journal:  BMC Psychiatry       Date:  2022-02-09       Impact factor: 3.630

5.  Effects of Repetitive Peripheral Sensory Stimulation in the Subacute and Chronic Phases After Stroke: Study Protocol for a Pilot Randomized Trial.

Authors:  Jéssica Borges Kroth; Benjamim Handfas; Glaucia Rodrigues; Francisco Zepeda; Marco Aurélio Oliveira; Danny J J Wang; Raymundo Machado de Azevedo Neto; Gisele Sampaio Silva; Edson Amaro; Isaac Olubunmi Sorinola; Adriana Bastos Conforto
Journal:  Front Neurol       Date:  2022-02-16       Impact factor: 4.003

Review 6.  The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression.

Authors:  Simeng Gu; Zhengming He; Qiuyue Xu; Jie Dong; Tingwei Xiao; Fei Liang; Xianjun Ma; Fushun Wang; Jason H Huang
Journal:  Front Psychiatry       Date:  2022-04-26       Impact factor: 5.435

7.  miR-129-5p targets FEZ1/SCOC/ULK1/NBR1 complex to restore neuronal function in mice with post-stroke depression.

Authors:  Fan Qinlin; Wang Bingqiao; Hu Linlin; Shi Peixia; Xie Lexing; Yang Lijun; Yang Qingwu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 8.  No add-on effect of tDCS on fatigue and depression in chronic stroke patients: A randomized sham-controlled trial combining tDCS with computerized cognitive training.

Authors:  Kristine M Ulrichsen; Knut K Kolskår; Geneviève Richard; Mads Lund Pedersen; Dag Alnaes; Erlend S Dørum; Anne-Marthe Sanders; Sveinung Tornås; Luigi A Maglanoc; Andreas Engvig; Hege Ihle-Hansen; Jan E Nordvik; Lars T Westlye
Journal:  Brain Behav       Date:  2022-06-06       Impact factor: 3.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.